Laryngospasm as an uncommon presentation in a patient with anti-N-methyl-D-aspartate receptor encephalitis: A case

Lu Wang1, Hong-Jun Su1, Guan-Jie Song2

  • 1Department of Neurology, Tianjin Baodi Hospital, Tianjin 301800, China.

PubMed
Abstract

Insights

Severe laryngospasms, a rare symptom, occurred in a 15-year-old diagnosed with anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis. This case highlights laryngospasm as an uncommon presentation of this autoimmune neurological disorder.

Area of Science:

  • Neurology
  • Immunology
  • Autoimmune Diseases

Background:

  • Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a rare autoimmune disorder.
  • Commonly presents with behavioral, speech, psychosis, seizure, and memory issues.
  • Laryngospasm is an infrequent manifestation.

Observation:

  • A 15-year-old female with normal development presented with seizures, behavioral problems, and speech impairment.
  • Developed severe laryngospasms requiring intubation and tracheotomy.
  • NMDAR antibodies detected in cerebrospinal fluid confirmed the diagnosis.

Findings:

  • The patient received immunotherapy (intravenous immunoglobulins and methylprednisolone).
  • Symptoms gradually improved, with significant recovery over 9 months.
  • Laryngospasm was identified as an uncommon clinical presentation.

Implications:

  • Highlights laryngospasm as a potential, albeit rare, symptom of anti-NMDAR encephalitis.
  • Suggests considering anti-NMDAR encephalitis in patients presenting with unexplained laryngospasm.
  • Emphasizes the importance of early diagnosis and treatment for improved patient outcomes.

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.0K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
Local Anesthetics: Adverse Effects01:12

Local Anesthetics: Adverse Effects

While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
453
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
514
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
422
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.6K